WWE in a Tight Spot

Recs

0

There comes a time in every wrasslin' match when the good guy battles back. World Wrestling Entertainment (NYSE: WWE) has been doing that all year, putting up solid revenues and profits despite slackening numbers in key areas. But today, the other shoe dropped, and it's a size 25, right across the solar plexus. But first, the comeback.

WWE's fourth-quarter and year-end release is surprisingly hype-free -- unlike the pay-per-view (PPV) extravaganzas that feed the top line. Total revenues were up 20% to $126.7 million. The all-important total number of PPV buys was juiced by timing, which added an event to the quarter, but major shindigs like WrestleMania brought in solid increases on their own, and other revenue streams posted impressive gains.

The firm cut costs too, and in the end, it meant earnings of $0.28 per share, which compares favorably to last year's fourth-quarter loss of $0.06. The full-year profit of $0.70 per share also represents a major comeback over last year's loss of $0.28. (Keep in mind that there were heavier restructuring costs in the prior year.)

But here's where the match gets uglier. Revenues for the full year were flat, just more than $374 million, and management guidance for next year forecasts a bit less than that. Earnings are expected to come in just less than $0.50 per share, a 29% drop from this year's triumph. Both those numbers are lower than analysts' expectations.

Does that mean investors should toss their popcorn and run for the exits? I'd argue against it. Admittedly, I've got a soft spot for WWE. It's the exact opposite of complex businesses like GE, (NYSE: GE), Microsoft (Nasdaq: MSFT), Ford (NYSE: F), or General Dynamics (NYSE: GD). WWE's simple business model and clear reporting -- plus chips 'n' armchair appeal -- made it a shoo-in for my list of stocks for lazy investors. Clearly, the McMahons know how to run this business. But in the face of their sobering predictions, it might be a good time to wait and watch, slack jawed and nervous, to see what happens next.

For more Fool investing tips that won't tax your brain (too much):

If you're feeling particularly lazy, the Fool's newsletter writers serve up market-whupping stock ideas every month.

Fool contributor Seth Jayson stopped hosting backyard wrestling matches when his wife learned how to perform the atomic drop. He has no position in any firm mentioned. View his Fool profile here.

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

TD AMERITRADE
more info
ShareBuilder
more info
Power E*Trade

more info
Scottrade
more info
Fool Disclosure

DocumentId: 508650, ~/Articles/ArticleHandler.aspx, 11/10/2009 7:33:38 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

The Must-Read Story on Fool.com
Health-Care Reform: A Tale of Two Chambers

Related Tickers

11/9/2009 4:00 PM
F $8.18 Up +0.43 +5.55%
Ford Motor Company CAPS Rating: **
GD $67.31 Up +1.73 +2.64%
General Dynamics C… CAPS Rating: ****
GE $15.85 Up +0.52 +3.39%
General Electric C… CAPS Rating: ****
WWE $15.23 Up +0.70 +4.82%
World Wrestling En… CAPS Rating: **
MSFT $28.99 Up +0.47 +1.65%
Microsoft Corp CAPS Rating: ***

Community: Investing Wiki

Term Of The Hour

Biotechnology: Biotechnology uses biological processes to solve problems in such areas as health and medicine, agriculture and manufacturing.

Want to learn more or edit this definition?
Click here to read more!